Luye Pharma Group Ltd.

SHSC:2186 Stock Report

Market Cap: HK$9.6b

Luye Pharma Group Future Growth

Future criteria checks 3/6

Luye Pharma Group is forecast to grow earnings and revenue by 16.9% and 10.2% per annum respectively. EPS is expected to grow by 17% per annum. Return on equity is forecast to be 7.7% in 3 years.

Key information

16.9%

Earnings growth rate

17.0%

EPS growth rate

Pharmaceuticals earnings growth11.1%
Revenue growth rate10.2%
Future return on equity7.7%
Analyst coverage

Low

Last updated21 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

SHSC:2186 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20268,0481,159N/AN/A3
12/31/20257,113941N/AN/A3
12/31/20246,396808N/AN/A3
6/30/20246,314770-654511N/A
3/31/20246,228652-1121,053N/A
12/31/20236,1435334301,595N/A
9/30/20236,0894955031,667N/A
6/30/20236,0354585761,739N/A
3/31/20236,0085315331,696N/A
12/31/20225,9826054901,654N/A
9/30/20225,541190-407946N/A
6/30/20225,099-224-1,304238N/A
3/31/20225,150-179-1,332210N/A
12/31/20215,200-134-1,359182N/A
9/30/20215,365210-854629N/A
6/30/20215,529554-3491,075N/A
3/31/20215,534630-3701,054N/A
12/31/20205,540707-3911,033N/A
9/30/20205,864955-1,0811,151N/A
6/30/20206,1891,204-1,7721,268N/A
3/31/20206,2731,300-1,6941,345N/A
12/31/20196,3581,396-1,6171,423N/A
9/30/20196,2291,434-1,3851,377N/A
6/30/20196,1011,472-1,1531,332N/A
3/31/20195,6371,388-1,2961,189N/A
12/31/20185,1731,303-1,4391,046N/A
9/30/20184,6711,231-5061,046N/A
6/30/20184,1681,1594271,046N/A
3/31/20183,9911,070N/A1,005N/A
12/31/20173,815981N/A964N/A
9/30/20173,547917N/A888N/A
6/30/20173,280852N/A812N/A
3/31/20173,099872N/A702N/A
12/31/20162,918892N/A592N/A
9/30/20162,784843N/AN/AN/A
6/30/20162,649794N/A390N/A
3/31/20162,606774N/A392N/A
12/31/20152,563755N/A395N/A
9/30/20152,481732N/AN/AN/A
6/30/20152,400710N/A423N/A
3/31/20152,472658N/A459N/A
12/31/20142,544606N/A495N/A
9/30/20142,705534N/A438N/A
6/30/20142,866462N/A382N/A
3/31/20142,690386N/A410N/A
12/31/20132,515310N/A439N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 2186's forecast earnings growth (16.9% per year) is above the savings rate (2.3%).

Earnings vs Market: 2186's earnings (16.9% per year) are forecast to grow faster than the Hong Kong market (11.7% per year).

High Growth Earnings: 2186's earnings are forecast to grow, but not significantly.

Revenue vs Market: 2186's revenue (10.2% per year) is forecast to grow faster than the Hong Kong market (7.8% per year).

High Growth Revenue: 2186's revenue (10.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 2186's Return on Equity is forecast to be low in 3 years time (7.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y